Share

May 05, 2009; 72 (18) Articles

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

S. Taillibert, L. A. Vincent, B. Granger, Y. Marie, C. Carpentier, R. Guillevin, A. Bellanger, K. Mokhtari, A. Rousseau, D. Psimaras, C. Dehais, M. Sierra del Rio, Y. Meng, F. Laigle-Donadey, K. Hoang-Xuan, M. Sanson, J. Y. Delattre
First published May 4, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181a413be
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
440

Share

Article Information

vol. 72 no. 18 1601-1606
DOI: 
https://doi.org/10.1212/WNL.0b013e3181a413be
PubMed: 
19414728
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published May 4, 2009.
Copyright & Usage: 
© 2009

Author Disclosures

    1. S. Taillibert, MD,
    2. L. A. Vincent, MSc,
    3. B. Granger, MD, PhD,
    4. Y. Marie, PhD,
    5. C. Carpentier, MSc,
    6. R. Guillevin, MD,
    7. A. Bellanger, MD,
    8. K. Mokhtari, MD,
    9. A. Rousseau, MD, PhD,
    10. D. Psimaras, MD,
    11. C. Dehais, MD,
    12. M. Sierra del Rio, MD,
    13. Y. Meng, MD, PhD,
    14. F. Laigle-Donadey, MD,
    15. K. Hoang-Xuan, MD, PhD,
    16. M. Sanson, MD, PhD and
    17. J. Y. Delattre, MD
  1. S. Taillibert, MD,
  2. L. A. Vincent, MSc,
  3. B. Granger, MD, PhD,
  4. Y. Marie, PhD,
  5. C. Carpentier, MSc,
  6. R. Guillevin, MD,
  7. A. Bellanger, MD,
  8. K. Mokhtari, MD,
  9. A. Rousseau, MD, PhD,
  10. D. Psimaras, MD,
  11. C. Dehais, MD,
  12. M. Sierra del Rio, MD,
  13. Y. Meng, MD, PhD,
  14. F. Laigle-Donadey, MD,
  15. K. Hoang-Xuan, MD, PhD,
  16. M. Sanson, MD, PhD and
  17. J. Y. Delattre, MD
  1. From Service de Neurologie Mazarin (S.T., L.A.V., D.P., C.D., M.S.d.R., Y.M., F.L.-D., K.H.-X., M.S., J.Y.D.), Département de Pharmacie (L.A.V., A.B.), Département de Santé Publique, Information Médicale et Biostatistiques (B.G.), Département de Neuro-radiologie (R.G.), and Laboratoire de Neuropathologie (K.M., A.R.), AP-HP, Hôpital de la Salpétrière, Paris; UPMC (B.G., A.R., D.P., C.D., K.H.-X., M.S., J.Y.D.), Paris 06; and Unité INSERM U711, Faculté Pierre et Marie Curie Paris VI (Y.M., C.C., K.M., A.R., K.H.-X., M.S., J.Y.D.), France.
  1. Address correspondence and reprint requests to Dr. Sophie Taillibert, Fédération de Neurologie Mazarin, Bat Mazarin, Hopital Salpétrière, 47-83 Boulevard de l’Hôpital, 75013 Paris, France sophie.taillibert{at}psl.aphp.fr
View Full Text

Article usage

Article usage: May 2009 to December 2022

AbstractFullPdfSource
May 20091784682Highwire
Jun 2009702021Highwire
Jul 2009473039Highwire
Aug 2009931921Highwire
Sep 2009522222Highwire
Oct 2009681918Highwire
Nov 2009712729Highwire
Dec 20094466Highwire
Jan 20104979Highwire
Feb 20104043Highwire
Mar 20103788Highwire
Apr 2010511411Highwire
May 20103736Highwire
Jun 201046108Highwire
Jul 20104877Highwire
Aug 20103353Highwire
Sep 201027106Highwire
Oct 20102142Highwire
Nov 20101134Highwire
Dec 20102123Highwire
Jan 20112555Highwire
Feb 20113974Highwire
Mar 20114523Highwire
Apr 20113272Highwire
May 20113168Highwire
Jun 20112245Highwire
Jul 20113544Highwire
Aug 20112323Highwire
Sep 201122164Highwire
Oct 20112834Highwire
Nov 20112521Highwire
Dec 20113600Highwire
Jan 20122852Highwire
Feb 20123010Highwire
Mar 20124011Highwire
Apr 20123212Highwire
May 20123810Highwire
Jun 20122501Highwire
Jul 20122422Highwire
Aug 20122359Highwire
Sep 20121521Highwire
Oct 20123002Highwire
Nov 20121401Highwire
Dec 20121501Highwire
Jan 20135833Highwire
Feb 20131900Highwire
Mar 20131931Highwire
Apr 20132500Highwire
May 20132100Highwire
Jun 20134711Highwire
Jul 20131012Highwire
Aug 20132721Highwire
Sep 20131500Highwire
Oct 20131800Highwire
Nov 20131010Highwire
Dec 20132334Highwire
Jan 20142102Highwire
Feb 20141421Highwire
Mar 2014920Highwire
Apr 20142000Highwire
May 20143100Highwire
Jun 2014911Highwire
Jul 20143700Highwire
Aug 20141422Highwire
Sep 20141111Highwire
Oct 20141310Highwire
Nov 2014300Highwire
Dec 20141100Highwire
Jan 20152011Highwire
Feb 20151411Highwire
Mar 20151533Highwire
Apr 20151212Highwire
May 20152501Highwire
Jun 20151000Highwire
Jul 2015810Highwire
Aug 2015911Highwire
Sep 2015912Highwire
Oct 20152000Highwire
Nov 20151500Highwire
Dec 20151500Highwire
Jan 20161800Highwire
Feb 20161100Highwire
Mar 20161611Highwire
Apr 20161200Highwire
May 20161200Highwire
Jun 20162110Highwire
Jul 20161400Highwire
Aug 20161300Highwire
Sep 20161600Highwire
Oct 20162300Highwire
Nov 20161500Highwire
Dec 20161500Highwire
Jan 20172200Highwire
Feb 20171800Highwire
Mar 20172900Highwire
Apr 20172100Highwire
May 20171911Highwire
Jun 2017600Highwire
Jul 20171200Highwire
Aug 20171400Highwire
Sep 20171600Highwire
Oct 20171400Highwire
Nov 20171510Highwire
Dec 2017800Highwire
Jan 20184110Highwire
Feb 20181600Highwire
Mar 2018811Highwire
Apr 20181310Highwire
May 20182632Highwire
Jun 20182300Highwire
Jul 20183311Highwire
Aug 20183200Highwire
Sep 20183420Highwire
Oct 20184032Highwire
Nov 20182500Highwire
Dec 20182100Highwire
Jan 20192700Highwire
Feb 20191300Highwire
Mar 2019700Highwire
Apr 20191301Highwire
May 20191810Highwire
Jun 2019701Highwire
Jul 20191710Highwire
Aug 20191300Highwire
Sep 20191111Highwire
Oct 20192000Highwire
Nov 20191211Highwire
Dec 20192211Highwire
Jan 20201600Highwire
Feb 20202121Highwire
Mar 2020811Highwire
Apr 2020501Highwire
May 20201400Highwire
Jun 20201932Highwire
Jul 20201900Highwire
Aug 20201422Highwire
Sep 20201200Highwire
Oct 20201700Highwire
Nov 20202321Highwire
Dec 20202011Highwire
Jan 2021700Highwire
Feb 20211844Highwire
Mar 20212422Highwire
Apr 20212600Highwire
May 20213700Highwire
Jun 20211400Highwire
Jul 20211900Highwire
Aug 20214610Highwire
Sep 20212600Highwire
Oct 20212123Highwire
Nov 20211310Highwire
Dec 20211000Highwire
Jan 20221600Highwire
Feb 20221900Highwire
Mar 20221300Highwire
Apr 20221360Highwire
May 20221100Highwire
Jun 20221200Highwire
Jul 20222511Highwire
Aug 2022811Highwire
Sep 20221231Highwire
Oct 20223300Highwire
Nov 20223123Highwire
Dec 20221600Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me